Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway
- PMID: 21669872
- PMCID: PMC3151097
- DOI: 10.1074/jbc.M111.256180
Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway
Abstract
Inflammatory processes play essential roles in the pathogenesis of tendinitis and tendinopathy. These events are accompanied by catabolic processes initiated by pro-inflammatory cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α). Pharmacological treatments for tendinitis are restricted to the use of non-steroidal anti-inflammatory drugs. Recent studies in various cell models have demonstrated that curcumin targets the NF-κB signaling pathway. However, its potential for the treatment of tendinitis has not been explored. Herein, we used an in vitro model of human tenocytes to study the mechanism of curcumin action on IL-1β-mediated inflammatory signaling. Curcumin at concentrations of 5-20 μm inhibited IL-1β-induced inflammation and apoptosis in cultures of human tenocytes. The anti-inflammatory effects of curcumin included down-regulation of gene products that mediate matrix degradation (matrix metalloproteinase-1, -9, and -13), prostanoid production (cyclooxygenase-2), apoptosis (Bax and activated caspase-3), and stimulation of cell survival (Bcl-2), all known to be regulated by NF-κB. Furthermore, curcumin suppressed IL-1β-induced NF-κB activation via inhibition of phosphorylation and degradation of inhibitor of κBα, inhibition of inhibitor of κB-kinase activity, and inhibition of nuclear translocation of NF-κB. Furthermore, the effects of IL-1β were abrogated by wortmannin, suggesting a role for the phosphatidylinositol 3-kinase (PI-3K) pathway in IL-1β signaling. Curcumin suppressed IL-1β-induced PI-3K p85/Akt activation and its association with IKK. These results demonstrate, for the first time, a potential role for curcumin in treating tendon inflammation through modulation of NF-κB signaling, which involves PI-3K/Akt and the tendon-specific transcription factor scleraxis in tenocytes.
Figures
![FIGURE 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3151097/bin/zbc0371173820001.gif)
![FIGURE 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3151097/bin/zbc0371173820002.gif)
![FIGURE 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3151097/bin/zbc0371173820003.gif)
![FIGURE 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3151097/bin/zbc0371173820004.gif)
![FIGURE 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3151097/bin/zbc0371173820005.gif)
![FIGURE 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3151097/bin/zbc0371173820006.gif)
![FIGURE 7.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3151097/bin/zbc0371173820007.gif)
![FIGURE 8.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3151097/bin/zbc0371173820008.gif)
![FIGURE 9.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3151097/bin/zbc0371173820009.gif)
![FIGURE 10.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3151097/bin/zbc0371173820010.gif)
![FIGURE 11.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3151097/bin/zbc0371173820011.gif)
![FIGURE 12.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3151097/bin/zbc0371173820012.gif)
Similar articles
-
NF-κB pathway as a molecular target for curcumin in diabetes mellitus treatment: Focusing on oxidative stress and inflammation.Cell Biochem Funct. 2024 Jun;42(4):e4030. doi: 10.1002/cbf.4030. Cell Biochem Funct. 2024. PMID: 38720663 Review.
-
Is tendinitis an inflammatory disease initiated and driven by pro-inflammatory cytokines such as interleukin 1β?Histol Histopathol. 2013 Aug;28(8):955-64. doi: 10.14670/HH-28.955. Epub 2013 Mar 6. Histol Histopathol. 2013. PMID: 23463583 Review.
-
Resveratrol modulates interleukin-1β-induced phosphatidylinositol 3-kinase and nuclear factor κB signaling pathways in human tenocytes.J Biol Chem. 2012 Nov 2;287(45):38050-63. doi: 10.1074/jbc.M112.377028. Epub 2012 Aug 30. J Biol Chem. 2012. PMID: 22936809 Free PMC article.
-
Sirt-1 is required for the inhibition of apoptosis and inflammatory responses in human tenocytes.J Biol Chem. 2012 Jul 27;287(31):25770-81. doi: 10.1074/jbc.M112.355420. Epub 2012 Jun 11. J Biol Chem. 2012. PMID: 22689577 Free PMC article.
-
IGF-1 and PDGF-bb suppress IL-1β-induced cartilage degradation through down-regulation of NF-κB signaling: involvement of Src/PI-3K/AKT pathway.PLoS One. 2011;6(12):e28663. doi: 10.1371/journal.pone.0028663. Epub 2011 Dec 14. PLoS One. 2011. PMID: 22194879 Free PMC article.
Cited by
-
Metabolic Syndrome and Tendon Disease: A Comprehensive Review.Diabetes Metab Syndr Obes. 2024 Apr 9;17:1597-1609. doi: 10.2147/DMSO.S459060. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38616994 Free PMC article. Review.
-
A Curcumin-Based Oral Gel Has Potential Protective Efficacy against Oral Mucositis: In Vitro Study.J Pers Med. 2023 Dec 19;14(1):1. doi: 10.3390/jpm14010001. J Pers Med. 2023. PMID: 38276216 Free PMC article.
-
Evaluation of curcumin for dermatologic conditions: a systematic review.Arch Dermatol Res. 2023 Dec 12;316(1):37. doi: 10.1007/s00403-023-02754-8. Arch Dermatol Res. 2023. PMID: 38085369 Review.
-
Nanocarrier-mediated curcumin delivery: An adjuvant strategy for CNS disease treatment.Exp Biol Med (Maywood). 2023 Nov;248(22):2151-2166. doi: 10.1177/15353702231211863. Epub 2023 Dec 6. Exp Biol Med (Maywood). 2023. PMID: 38058006 Free PMC article. Review.
-
Therapeutic potential of natural products in inflammation: underlying molecular mechanisms, clinical outcomes, technological advances, and future perspectives.Inflammopharmacology. 2023 Dec;31(6):2857-2883. doi: 10.1007/s10787-023-01366-y. Epub 2023 Nov 11. Inflammopharmacology. 2023. PMID: 37950803 Review.
References
-
- Maffulli N., Wong J., Almekinders L. C. (2003) Clin. Sports Med. 22, 675–692 - PubMed
-
- Almekinders L. C. (1998) J. Am. Acad. Orthop. Surg. 6, 157–164 - PubMed
-
- Riley G. (2004) Rheumatology 43, 131–142 - PubMed
-
- Sendzik J., Shakibaei M., Schäfer-Korting M., Lode H., Stahlmann R. (2010) Int. J. Antimicrob. Agents 35, 366–374 - PubMed
-
- Sendzik J., Shakibaei M., Schäfer-Korting M., Stahlmann R. (2005) Toxicology 212, 24–36 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous